Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,693 | 100 | 93.0% |
| Education | $192.98 | 2 | 4.9% |
| Travel and Lodging | $87.00 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $888.75 | 23 | $0 (2024) |
| Allergan, Inc. | $424.02 | 6 | $0 (2021) |
| Alimera Sciences, Inc. | $418.11 | 3 | $0 (2019) |
| Glaukos Corporation | $316.13 | 5 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $301.54 | 5 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $183.42 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $169.85 | 8 | $0 (2024) |
| RxSight Inc | $167.13 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $144.40 | 5 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $127.68 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $640.47 | 25 | Glaukos Corporation ($136.29) |
| 2023 | $705.56 | 26 | Alcon Vision LLC ($267.42) |
| 2022 | $430.33 | 16 | Alcon Vision LLC ($281.25) |
| 2021 | $408.26 | 13 | Novartis Pharmaceuticals Corporation ($108.86) |
| 2020 | $275.95 | 6 | Mallinckrodt Hospital Products Inc. ($92.99) |
| 2019 | $1,044 | 11 | Alimera Sciences, Inc. ($418.11) |
| 2018 | $469.20 | 6 | Allergan Inc. ($212.71) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Dry eyes | ||||||
| 11/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Ophthalmology | ||||||
| 09/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Dry eyes | ||||||
| 07/16/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $38.69 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: EYE CARE | ||||||
| 05/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: EYE CARE | ||||||
| 05/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/08/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 05/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Ophthalmology | ||||||
| 04/12/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Optics | ||||||
| 04/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Ophthalmology | ||||||
| 03/27/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Dry eyes | ||||||
| 03/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/22/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $136.29 | General |
| Category: Glaucoma | ||||||
| 02/14/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Ophthalmology | ||||||
| 01/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,273 | 1,424 | $495,337 | $124,628 |
| 2022 | 12 | 680 | 754 | $214,588 | $57,784 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 62 | 105 | $241,500 | $40,891 | 16.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 306 | 326 | $60,400 | $26,584 | 44.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 234 | 234 | $50,310 | $21,158 | 42.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 45 | 45 | $54,000 | $11,802 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 71 | $9,585 | $4,184 | 43.6% |
| 92250 | Photography of the retina | Office | 2023 | 137 | 139 | $15,290 | $3,574 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 101 | $8,585 | $3,558 | 41.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 42 | 50 | $6,500 | $3,277 | 50.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 72 | 107 | $28,997 | $2,864 | 9.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 54 | 57 | $6,270 | $2,354 | 37.5% |
| 92134 | Imaging of retina | Office | 2023 | 81 | 82 | $5,330 | $2,242 | 42.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 72 | 74 | $4,810 | $1,693 | 35.2% |
| 92025 | Ct scan of cornea | Office | 2023 | 13 | 14 | $2,240 | $322.21 | 14.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 19 | 19 | $1,520 | $126.94 | 8.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 28 | 44 | $100,800 | $16,885 | 16.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 150 | 150 | $33,170 | $14,463 | 43.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 146 | 151 | $29,455 | $11,825 | 40.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 76 | $6,460 | $2,924 | 45.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 34 | 52 | $7,800 | $2,649 | 34.0% |
| 92250 | Photography of the retina | Office | 2022 | 83 | 83 | $9,250 | $2,115 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $2,970 | $1,487 | 50.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 34 | 49 | $13,173 | $1,439 | 10.9% |
| 92134 | Imaging of retina | Office | 2022 | 46 | 46 | $3,675 | $1,284 | 34.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 28 | 28 | $3,280 | $1,165 | 35.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 40 | 41 | $3,295 | $953.81 | 28.9% |
About Thomas Briggs
Thomas Briggs is a Ophthalmology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1780117978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Briggs has received a total of $3,973 in payments from pharmaceutical and medical device companies, with $640.47 received in 2024. These payments were reported across 103 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,693).
As a Medicare-enrolled provider, Briggs has provided services to 1,953 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $182,412. Data is available for 2 years (2022–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Student in an Organized Health Care Education/Training Program, Ophthalmology
- Location Tulsa, OK
- Active Since 04/05/2017
- Last Updated 05/01/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1780117978
Products in Payments
- HYDRUS Microstent (Device) $451.99
- Iluvien (Drug) $418.11
- AcrySof (Device) $146.65
- Cequa (Drug) $142.58
- iDose (Device) $136.29
- ENVISTA (Device) $125.04
- RXSIGHT INJECTOR HANDPIECE (Device) $124.28
- MIEBO (Drug) $123.83
- ACTHAR (Biological) $121.00
- OMIDRIA (Drug) $118.23
- XIIDRA (Drug) $114.22
- TEPEZZA (Drug) $113.60
- XEN (Device) $112.72
- STELLARIS (Device) $110.72
- AcrySof IQ VIVITY IOL (Device) $104.19
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $100.63
- TEPEZZA (Biological) $99.92
- Catalys Laser System (Device) $87.00
- TYRVAYA (Drug) $85.69
- ARGOS (Device) $64.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Tulsa
Dr. Thomas Finley, Md, MD
Ophthalmology — Payments: $12,116
Dr. Kelli Dyer, D.o, D.O
Ophthalmology — Payments: $6,753
Jamal Siddiqui, M.d, M.D
Ophthalmology — Payments: $6,256
Neha Sangal
Ophthalmology — Payments: $4,653
Shehzad Batliwala, D.o, D.O
Ophthalmology — Payments: $4,278
Marc Goldberg, Md, MD
Ophthalmology — Payments: $4,188